Biosciences, announced that its collaboration partner, PeriNess has entered into a Clinical Study Agreement to support an ...

OS Therapies (NYSE-A: OSTX) ("OS Therapies" or "the Company"), a clinical-stage immunotherapy and Antibody Drug Conjugate (ADC) biopharmaceutical company, today announced that OST-HER2 is featured in ...

Biosciences’ collaboration partner, PeriNess has entered into a Clinical Study Agreement to support an exploratory clinical ...

BETTENDORF, Iowa (KWQC) - A Bettendorf teen passed way after a battle with bone cancer on March 20. 15-year-old Zach Maxwell ...

We recently published a list of 10 Penny Stocks With Huge Upside Potential According To Analysts. In this article, we are ...

Sophie Fulton was diagnosed with a rare bone cancer last year, and after losing part of her leg is now struggling with living ...

A devastated family are being forced to leave their home of 12 years after their daughter was diagnosed with rare bone cancer ...

The U.S. Food and Drug Administration (FDA) has approved a new class of antibiotics for treating uncomplicated urinary tract ...

EQT Foundation is announcing a new global call for proposals under its Breakthrough Science grants program, awarding between ?25,000 to ?100,000 for pioneering researchers tackling women's health ...

OnDefend, a leader in preventative cybersecurity testing and advisory services, today announced the launch of its Ransomware Defense Validation (RDV) service. Developed with direct input from ...